AI-Powered Learning: Exploring AI with CluePoints’ François Torche
Join us for an engaging conversation between Julian Minett, CEO of Spencer Group, and François Torche, Chief Product & Technology Officer & Co-Founder at CluePoints
Mats Klaar’s CEO Insights: Navigating Success with Viedoc
Mats Klaar, CEO at Viedoc, joins Spencer Group’s CEO, Julian Minett, for an insightful conversation about his journey and the remarkable impact of Viedoc in the world of clinical data management.
DIA Global 2023
Spencer Group’s CEO, Julian Minett, Shares Insights from DIA 2023 Event: AI, Diversity, and Patient Centricity at the Forefront
Outsourcing Clinical Trials and Clinical Trials Supply Event in Copenhagen
Julian Minett, CEO of Spencer Group is looking forward to attending this year’s Outsourcing Clinical Trials and Clinical Trials Supply Event in Copenhagen, 25th – 26th October.
Spencer Group attend the Scrip Awards
Spencer Group were delighted to attend the 17th edition of the Scrip Awards on the 2nd December, hosted live in London. The Scrip Awards honours the outstanding accomplishments of those improving human healthcare worldwide…
Decentralised trials, is this the new normal for clinical trials?
We are excited to be speaking to Steve Geffon, a highly experienced commercial lead in the eclinical and services market. Steve is the CCO of Science37, an organisation with over 6 years in virtual/decentralised trials.
What are the possible implications of Covid-19 on the biopharmaceutical and the wider pharmaceutical markets?
Steve Kent is currently Non-Executive Chairman at Phlexglobal, 4ways and Pharmaspectra, as well as Non-Executive Director at Imagen Therapeutics. During Steve’s time as an executive
What are the possible implications of Covid-19 on the pharmaceutical technology sector?
Steve Powell is a renowned, international expert with a career spanning over 30 years within pharmaceutical technology. He has worked for organisations such as GSK and Phase Forward and now has a number of NED and Chair positions
Neil Rotherham: What is the impact of Covid-19 on the pharmaceutical technology market?
Neil Rotherham is a serial entrepreneur with over 25 year’s experience in the pharmaceutical and medical technology markets with proven experience of running and building businesses in the UK and USA.
What implications will coronavirus have on higher education?
Geoff Webster is Managing Director of CEG Digital, a division of Cambridge Education Group specialising in partnering with high quality UK, EU, US and Australian universities to enable the delivery of part time, flexible